NO | Wer | Cas na | Bikaranînî | Nîşana kalîteya key | ||||
Qiralîtî | Isomer | Nepenîtiya taybetî | * Max1 | Şilî | ||||
1 | Fmoc-Cys (ACM) -OH | 8606060-81-3 | Girêdana disulfide | ≥99.0% | ≤0.1% | ≤0.1% | ≤ %,2% | ≤1.0% |
2 | Fmoc-Cys (MMT) -OH | 177582-21-7 | Girêdana disulfide | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
3 | Fmoc-Cys (4-AllyLbutyrate) -OH | / | Girêdana disulfide | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
4 | MPA (TRT) -OH | 27144-18-9 | Dawiya rêzê | 999.5% | / | ≤0.1% | ≤ %,2% | ≤1.0% |
5 | Fmoc-thr (TBU) -OL | 189337-28-8 | Octreotide | ≥97.0% | ≤2.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | Fmoc-D-Arg (PBF) -OH | 187618-60-6 | Desmoprressin | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤2.0% |
7 | FMOC-GLY-GLY-OH | 35665-38-4 | Bivalirudin | 999.5% | / | ≤0.1% | ≤ %,2% | ≤1.0% |
8 | FMOC-GLY-GLY-GLY-OH | 170941-79-4 | Terlipressin | 999.5% | / | ≤0.1% | ≤ %,2% | ≤1.0% |
9 | FMOC-GLY-GLY-GLY-GLY-OH | / | Bivalirudin | 999.5% | / | ≤0.1% | ≤ %,2% | ≤1.0% |
10 | FMOC-GLY-ASP (TBU) -OH | / | Bivalirudin | 999.5% | / | ≤0.15% | ≤ %,2% | ≤1.0% |
11 | Boc-cys (TRT) -OH | 21947-98-8 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
12 | Boc-arg (pbf) -oh | 200124-22-7 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
13 | Boc-ala-oh | 15761-38-3 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
14 | Boc-D-Phe-Oh | 18942-49-9 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
15 | BOC-GLY-OH | 4530-20-5 | Dawiya rêzê | 999.5% | / | ≤0.1% | ≤ %,2% | ≤1.0% |
16 | Boc-Lys (Boc) -oh.Dcha | 15098-69-8 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
17 | BOC-SER (TBU) -OH | 7738-22-9 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
18 | Boc-thr (tbu) -oh | 13734-40-2 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
19 | Boc-D-Ala-Oh | 7764-95-6 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
20 | Boc-Met-Oh | 2488-15-5 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
21 | Boc-Tyr (tbu) -oh | 47375-34-8 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
22 | BOC-D-ARG (PDF) -OH | 187618-60-6 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
23 | BOC-ASP (Otbu) -oh.dcha | 1913/12/8 | Dawiya rêzê | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
24 | Fmoc-Homoarg (PBF) -OH | 1159680-21-3 | Eptifibatiide | ≥98.5% | ≤ %,2% | / | ≤0.5% | ≤2.0% |
25 | Fmoc-ASP-Otbu | 129460-09-9 | Thimalfasin | 999.5% | ≤0.1% | ≤0.1% | ≤ %,2% | ≤1.0% |
26 | Fmoc-Tyr (Me) -OH | 77128-72-4 | Carbetocin | ≥98.5% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
27 | Fmoc-orn (boc) -oh | 109425-55-0 | Atosiban Omnipressin Daptomycin | 999.5% | ≤0.1% | ≤0.1% | ≤ %,2% | ≤2.0% |
28 | Fmoc-D-Tyr (ET) -OH | 162502-65-0 | Atosiban | 999.5% | ≤0.1% | ≤0.1% | ≤ %,2% | ≤1.0% |
29 | Fmoc-asp (oall) -oh | 146982-24-3 | Melanotan | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
30 | AC-NLE-OH | 15891-49-3 | Melanotan | ≥99.0% | / | ≤2.3% | ≤2.3% | ≤1.0% |
31 | Fmoc-NLE-OH | 77284-32-3 | Melanotan Afamelanotide | ≥99.0% | / | ≤2.3% | ≤2.3% | ≤1.0% |
32 | Ac-glu (otbu) -oh | 84192-88-1 | Agireline Acetyl octapeptide-3 | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
33 | Ac-β-ala-oh · dcha | / | Acetyl Tetrapeptide-5 | ≥99.0% | / | ≤2.3% | ≤2.3% | ≤1.0% |
34 | Fmoc-ß-Ala-OH | 35737-10-1 | Acetyl Tetrapeptide-5 | 999.5% | / | ≤0.1% | ≤ %,2% | ≤1.0% |
35 | Fmoc-hyp (tbu) -oh | 122996-47-8 | Icatibant | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
36 | Fmoc-Thi-OH | 130309-35-2 | Icatibant | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
37 | Fmoc-D-Tic-Oh | 130309-33-0 | Icatibant | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
38 | Fmoc-Oic-Oh | 130309-37-4 | Icatibant | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
39 | Boc-Sar-Oh | 13734-36-6 | Saralasin | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
40 | Fmoc-Sar-Oh | 77128-70-2 | Saralasin | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
41 | FMOC-TYR (so3na) -oh.h2o | 106864-37-3 | SostedaLe | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
42 | FMOC-D-ASP (Otbu) -OH | 112883-39-3 | Daptomycin | ≥98.5% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
43 | Ac-ser (tbu) -oh | 77285-09-7 | Afamelanotide | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
44 | Boc-homocys (TRT) -OH | 201419-16-1 | Depreotide | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
45 | Fmoc-homocys (TRT) -OH | 167015-23-8 | Depreotide | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
46 | Fmoc-Dab-Oh | 161420-87-7 | Snake Venom | ≥99.0% | ≤ %,2% | ≤2.3% | ≤2.3% | ≤1.0% |
* Max1 = Paqijiya naskirî ya Max
Nîşana din:
- acîdê acetîk: ≤0.02% (hemî hilber)
- Ethyl Acetate: ≤0.5% (hemî hilber)
- alkol: ≤0.5% (hemî hilber)
- Max Nekêşbar: FMOC-TRP (BOC) -OH (143824-78-6) ≤% 7.3%; Yên din ≤ %.2%